Metformin reduces cell migration and down-regulates epithelial to mesenchymal transition (EMT) by AMPK/Foxo3a pathway in human intrahepatic cholangiocarcinoma (CCA). Issue 1 (16th February 2017) - Di Matteo, S.; Costantini, D.; Nevi, L.; Lustri, A.; Napoletano, C.; Faccioli, J.; Giulitti, F.; Manzi, E.; DeRose, A.M.; Bragazzi, M.C.; Grazi, G.; Berloco, P.B.; et al.